4.7 Article

Role of the cGAS-STING pathway in regulating the tumor-immune microenvironment in dMMR/MSI colorectal cancer

Related references

Note: Only part of the references are listed.
Article Oncology

DNA Sensing in Mismatch Repair-Deficient Tumor Cells Is Essential for Anti-tumor Immunity

Changzheng Lu et al.

Summary: This study demonstrates the importance of DNA sensing within tumor cells in triggering anti-tumor immunity in dMLH1 tumors, providing new mechanisms and biomarkers for anti-dMMR-cancer immunotherapy.

CANCER CELL (2021)

Article Oncology

MLH1 Deficiency-Triggered DNA Hyperexcision by Exonuclease 1 Activates the cGAS-STING Pathway

Junhong Guan et al.

Summary: This study revealed that loss of MutLa subunit MLH1 leads to production of neoantigens and activation of the cGAS-STING pathway, affecting DNA repair process and ultimately causing chromosomal abnormalities and DNA release. This unknown MMR mechanism has significant implications for genome stability and cancer therapy.

CANCER CELL (2021)

Article Immunology

TREX1 as a Novel Immunotherapeutic Target

Wayne O. Hemphill et al.

Summary: Mutations in the TREX1 exonuclease are linked to autoimmune diseases in humans and mice. Inhibition of TREX1 could potentially be a novel immunotherapeutic strategy. Additionally, TREX1 and the cGAS-STING pathway are implicated in the tumor microenvironment.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN-driven CCL5 and CXCL10

Courtney Mowat et al.

Summary: The recruitment and activation of CD8(+) T cells in dMMR CRCs depend on the overexpression of CCL5 and CXCL10, which is essential for successful anti-tumor immunity. This strategy represents a potential therapeutic approach to enhance TIL recruitment and local priming in CRCs.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Review Oncology

Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers

Vito Amodio et al.

Summary: A subset of colorectal cancers with mismatch repair deficiency are sensitive to immune checkpoint inhibitors, but some patients show primary resistance or develop acquired resistance. Changes in the Wnt and JAK-STAT signaling pathways, as well as alterations in the antigen presentation machinery, are associated with resistance to CPIs in these patients. Understanding the mechanistic basis of immune evasion in CRC provides rationale for innovative strategies to increase the subset of patients benefiting from CPIs.

CANCERS (2021)

Review Oncology

Microsatellite Instability in Colorectal Cancers: Carcinogenesis, Neo-Antigens, Immuno-Resistance and Emerging Therapies

Violaine Randrian et al.

Summary: A defective mismatch repair system leads to microsatellite instability, resulting in high mutation burden in tumors, with some mutations producing neo-antigens that trigger anti-tumoral immune response. Non-metastatic MSI tumors have high immune infiltrates and good prognosis, while metastatic MSI tumors, having evaded immune response, are associated with poor prognosis and chemoresistance. Immune checkpoint inhibitors (ICI) are effective in dMMR/MSI mCRC, but some patients may develop primary or secondary resistance, prompting the development of strategies targeting other immune checkpoints or utilizing vaccination and modification of microbiota to overcome resistance.

CANCERS (2021)

Article Oncology

Colorectal cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Oncology

cGAS-STING, an important pathway in cancer immunotherapy

Minlin Jiang et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Review Biochemistry & Molecular Biology

cGAS/STING: novel perspectives of the classic pathway

Menghui Gao et al.

MOLECULAR BIOMEDICINE (2020)

Review Biochemistry & Molecular Biology

Comprehensive review of targeted therapy for colorectal cancer

Yuan-Hong Xie et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Gastroenterology & Hepatology

Immunotherapy in colorectal cancer: rationale, challenges and potential

Karuna Ganesh et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Review Immunology

STING pathway agonism as a cancer therapeutic

Blake A. Flood et al.

IMMUNOLOGICAL REVIEWS (2019)

Review Gastroenterology & Hepatology

Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies

NaNa Keum et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Review Biochemistry & Molecular Biology

STING: a master regulator in the cancer-immunity cycle

Yuanyuan Zhu et al.

MOLECULAR CANCER (2019)

Article Oncology

STING signaling is a potential immunotherapeutic target in colorectal cancer

Hong Jae ChonL et al.

JOURNAL OF CANCER (2019)

Review Immunology

The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer

Tuo Li et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2018)

Review Biochemistry & Molecular Biology

The Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment

Samuel F. Bakhoum et al.

Review Immunology

STING Signaling in Cancer Cells: Important or Not?

Olga Sokolowska et al.

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2018)

Article Multidisciplinary Sciences

Cytoplasmic chromatin triggers inflammation in senescence and cancer

Zhixun Dou et al.

NATURE (2017)

Article Multidisciplinary Sciences

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

Dung T. Le et al.

SCIENCE (2017)

Article Multidisciplinary Sciences

Decreased expression of STING predicts poor prognosis in patients with gastric cancer

Shushu Song et al.

SCIENTIFIC REPORTS (2017)

Article Multidisciplinary Sciences

MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment

RaeAnna Wilson et al.

NATURE COMMUNICATIONS (2016)

Article Multidisciplinary Sciences

STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity

Olivier Demaria et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Review Cell Biology

The Inflammatory Chemokine CCL5 and Cancer Progression

Donatella Aldinucci et al.

MEDIATORS OF INFLAMMATION (2014)

Article Biochemistry & Molecular Biology

STING Recognition of Cytoplasmic DNA Instigates Cellular Defense

Takayuki Abe et al.

MOLECULAR CELL (2013)

Article Biochemistry & Molecular Biology

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

Jianjiong Gao et al.

SCIENCE SIGNALING (2013)

Review Oncology

Germline deletions in the EPCAM gene as a cause of Lynch syndrome - literature review

Katarzyna Tutlewska et al.

HEREDITARY CANCER IN CLINICAL PRACTICE (2013)

Article Gastroenterology & Hepatology

Colorectal cancer molecular biology moves into clinical practice

Colin C. Pritchard et al.

Article Genetics & Heredity

Recurrence and Variability of Germline EPCAM Deletions in Lynch Syndrome

Roland P. Kuiper et al.

HUMAN MUTATION (2011)

Article Multidisciplinary Sciences

A diverse range of gene products are effectors of the type I interferon antiviral response

John W. Schoggins et al.

NATURE (2011)

Article Gastroenterology & Hepatology

Microsatellite Instability in Colorectal Cancer

C. Richard Boland et al.

GASTROENTEROLOGY (2010)

Article Cell Biology

Activation of the interferon system by short-interfering RNAs

CA Sledz et al.

NATURE CELL BIOLOGY (2003)